Cargando…

Finding Clues to Protect Against Coronary Atherosclerosis via Traditional Risk Factors

Detalles Bibliográficos
Autores principales:	Tada, Hayato, Takamura, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164598/ https://www.ncbi.nlm.nih.gov/pubmed/35896354 http://dx.doi.org/10.5551/jat.ED211

Ejemplares similares

What is the Role of Cholesterol Absorption and Synthesis Biomarkers in Humans?
por: Tada, Hayato, et al.
Publicado: (2023)

Exquisite Balance Between Cholesterol Synthesis and Cholesterol Absorption in Human
por: Tada, Hayato, et al.
Publicado: (2023)

Triglycerides on the Rise!
por: Tada, Hayato, et al.
Publicado: (2021)

Targeted Panel Sequencing will Boost Detection of Genetic Backgrounds of Familial Hypercholesterolemia in the World's Most Populous Country
por: Tada, Hayato, et al.
Publicado: (2020)

The Effect of Diet on Cardiovascular Disease, Heart Disease, and Blood Vessels
por: Tada, Hayato, et al.
Publicado: (2022)

Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
por: Tada, Hayato, et al.
Publicado: (2019)

Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery Disease
por: Tada, Hayato
Publicado: (2021)

Finding relief at the end of the (Carpal) tunnel: Electrophysiological clues
por: Yip, Chun Wai, et al.
Publicado: (2013)

Understanding COVID-19 in children may provide clues to protect at-risk populations
por: Do, Lien Anh Ha, et al.
Publicado: (2020)

Eggplant-Like Coronary Aneurysm With Massive Thrombus
por: Yamagami, Kan, et al.
Publicado: (2022)

Sex Differences in the Association between Traditional Vascular Risk Factors and Subclinical Carotid Atherosclerosis in Taiwan
por: Lin, Gen-Min, et al.
Publicado: (2017)

The Estimated Absolute Risk of Coronary Artery Disease and Subclinical Atherosclerosis
por: Kadota, Aya
Publicado: (2021)

Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
por: Fender, Anke C., et al.
Publicado: (2020)

Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents
por: Tada, Hayato, et al.
Publicado: (2021)

Individualized Treatment for Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Protective Effects of Chinese Traditional Medicine Longhu Rendan against Atherosclerosis via Negative Regulation of LOX-1
por: Yan, Sishan, et al.
Publicado: (2018)

Clues from hypercalcaemia
por: Nicholson, S, et al.
Publicado: (2002)

Are we “CLUE” less?
por: Sogi, Girish Malleshappa
Publicado: (2021)

Inflammation, Atherosclerosis and Coronary Artery Disease
por: Momiyama, Yukihiko, et al.
Publicado: (2016)

Contribution of Remnant Cholesterol to Coronary Atherosclerosis
por: Ohmura, Hirotoshi
Publicado: (2022)

HDL signaling and protection against coronary artery atherosclerosis in mice
por: Trigatti, Bernardo L, et al.
Publicado: (2016)

MR Imaging Findings of Ovarian Cystadenofibroma: Clues for Making the Differential Diagnosis from Ovarian Malignancy
por: Byun, Jae Young
Publicado: (2006)

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks
por: Tada, Hayato, et al.
Publicado: (2023)

Your Foot Can Help Predict Your Cardiovascular Risk
por: Kawashiri, Masa-aki, et al.
Publicado: (2023)

Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients
por: Pencak, Przemysław, et al.
Publicado: (2013)

Traditional Chinese Medicine Protects against Cytokine Production as the Potential Immunosuppressive Agents in Atherosclerosis
por: Ren, Yan, et al.
Publicado: (2017)

Derivation of a Coronary Age Calculator Using Traditional Risk Factors and Coronary Artery Calcium: The Multi‐Ethnic Study of Atherosclerosis
por: Blaha, Michael J., et al.
Publicado: (2021)

Intramembrane proteases protect from atherosclerosis
por: Mentrup, Torben, et al.
Publicado: (2019)

Long Covid: clues about causes
por: Liew, Felicity, et al.
Publicado: (2023)

Alzheimer Disease: Clues from traditional and complementary medicine
por: Cooper, Edwin L., et al.
Publicado: (2017)

Metabolic Mediators of the Effects of Family History and Genetic Risk Score on Coronary Heart Disease—Findings From the Malmö Diet and Cancer Study
por: Fritz, Josef, et al.
Publicado: (2017)

Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors
por: Lechner, Katharina, et al.
Publicado: (2019)

Coronary artery calcium among patients with heterozygous familial hypercholesterolaemia
por: Tada, Hayato, et al.
Publicado: (2023)

Low-Density Lipoprotein Cholesterol Level cannot be too Low: Considerations from Clinical Trials, Human Genetics, and Biology
por: Tada, Hayato, et al.
Publicado: (2020)

Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 gene
por: Tada, Hayato, et al.
Publicado: (2020)

Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome Information
por: Tada, Hayato, et al.
Publicado: (2021)

Children with Severe Hypercholesterolemia Caused by a Pathogenic Mutation in ABCG5
por: Tada, Hayato, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
por: Jin, Leigang, et al.
Publicado: (2016)

Neutrophil-to-Lymphocyte Ratio for Risk Assessment in Coronary Artery Disease and Carotid Artery Atherosclerosis
por: Park, Jun-Bean
Publicado: (2016)

Lipoprotein(a) and the Risk of Chronic Kidney Disease in Hospitalized Japanese Patients
por: Tada, Hayato, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_keq550o8u96kmeou9dmdg8t1f2